HIGHLIGHTS
- who: Huan Wang from the Master of Medicine, Department of Gynaecology, Harbin Medical University Republic of China have published the paper: Efficacy evaluation of albumin-bound paclitaxel combined with carboplatin as neoadjuvant chemotherapy for primary epithelial ovarian cancer, in the Journal: (JOURNAL)
- what: The aim for advanced ovarian cancer is satisfactory cytoreductive surgery. The authors have compared the efficacy of Nab-TC and TC regimens as NAC for epithelial ovarian cancer to ascertain the advantages of albumin binding and establish the utility of paclitaxel as therapy for ovarian cancer. The study showed that the achievement . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.